BATELBERO
Live / Allowed — Published for opposition (as of 27 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 25 Aug 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 50071271
- Mark type
- Word mark
- Filed
- 25 Aug 2026
- Published for opposition
- 27 Oct 2026
- Attorney of record
- Andrea Christensen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, cancer, cachexia, hypertension, migraine, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Antifungal preparations; Smoking cessation preparations; Vaccines for human use
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 27 Oct 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Oct 2026 — PUBLISHED FOR OPPOSITION
- 21 Oct 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Sept 2026 — ASSIGNED TO EXAMINER
- 25 Aug 2026 — APPLICATION FILING RECEIPT MAILED
- 25 Aug 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 25 Aug 2026 — NEW APPLICATION ENTERED